In this work, biocomposites of poly (3-hydroxybutyrate) (PHB) / calcium carbonate from Rhea Americana eggshells were prepared and the effects of the addition of the inorganic filler in the polymeric matrix were assessed. The residue (powder) of the eggshell calcined at 400 ºC or in natura was inserted into a PHB solution for preparation of films via casting. Powder samples were characterized by X-Ray Fluorescence (XRF), X-Ray diffraction (XRD) and Thermogravimetry (TG/ DTG) and films were characterized by X-Ray diffraction (XRD), Scanning Electron Microscopy (SEM) and biodegradation tests according to the ASTM G 160-03 norm: the results were reported as weight loss and visual inspection by optical microscopy (OM). From the results of the XDR, it was perceived that the peaks in the diffractograms of the powder obtained by milling the Rhea Americana eggshells corresponded to the diffraction patterns of the Calcite crystals, which is a calcium carbonate polyform, and that the calcination preserved the crystalline structure, maintaining the calcium carbonate in the samples. For the biocomposites, a peak characteristic to the calcium carbonate in 29.57º was detected, indicating the insertion of the filler to the polymer matrix. Through SEM the presence of small agglomerates, probably due to polymer particles that were not dissolved, was observed for the pure PHB film. With the addition of the filler in natura a greater porosity was formed in the surface of the biocomposite films, and with the calcined filler, homogeneous films with reduced porosity were obtained. From the weight loss and OM results, it was observed that the filler inserted into the polymeric matrix catalyzes the biodegradation process up to 60 days evaluation in different ways, depending on the type of sample used.
Studies about in vitro biodegradation of polymers have grown considerably due to the wide application of biodegradable polymers in biomedical areas. The objective of this study was to prepare bionanocomposites films of PHB, PEG, and organoclays by solution intercalation, and to evaluate the morphology, structure, hydrolytic degradation through FTIR and the calculation of carbonyl content. The results showed that bionanocomposites displayed intermediated dispersion of the filler, the polymer chains were intercalated into the organoclay layers and was observed some degree of exfoliation. There was an influence of PEG and of the clay on the degradation of the polymer, this fact was observed due to the decrease in the intensity of PHB carbonyl band in the region around 1275 cm-1 , affecting the amorphous and crystalline regions of the polymer. This reduction can be associated with the increase in hydrophilicity of the polymer caused by the presence of the PEG and clay, suggesting the possibility of increasing the biodegradability of the pure polymer. In future research, there will be made characterizations to know if these materials can be used in medical devices.
Polymeric foams are cell structures (porous microstructures) that have been frequently made from synthetic polymers for use in the development of food packaging. Due to the problems concerning the environmental impact caused by polymers from the petrochemical industry, the foams have been more recently studied from biodegradable polymers. However, the polymer materials obtained are usually susceptible to moisture, thus conditioning the collapse of the porous structure of the material. As an alternative, the composite foams have been investigated from nanofillers such as clays, cellulose, nanoparticles, among others. This chapter aims to analyze the recent advances in the studies of composite foams.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.